vs
Side-by-side financial comparison of Aterian, Inc. (ATER) and ENANTA PHARMACEUTICALS INC (ENTA). Click either name above to swap in a different company.
ENANTA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($18.6M vs $15.1M, roughly 1.2× Aterian, Inc.). Aterian, Inc. runs the higher net margin — -52.5% vs -64.1%, a 11.6% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -38.5%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-11.8M). Over the past eight quarters, ENANTA PHARMACEUTICALS INC's revenue compounded faster (4.5% CAGR vs -13.5%).
Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
ATER vs ENTA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.1M | $18.6M |
| Net Profit | $-7.9M | $-11.9M |
| Gross Margin | 56.1% | — |
| Operating Margin | -51.1% | -60.5% |
| Net Margin | -52.5% | -64.1% |
| Revenue YoY | -38.5% | 9.8% |
| Net Profit YoY | -512.2% | 46.4% |
| EPS (diluted) | — | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.1M | $18.6M | ||
| Q3 25 | $19.0M | $15.1M | ||
| Q2 25 | $19.5M | $18.3M | ||
| Q1 25 | $15.4M | $14.9M | ||
| Q4 24 | $24.6M | $17.0M | ||
| Q3 24 | $26.2M | $14.6M | ||
| Q2 24 | $28.0M | $18.0M | ||
| Q1 24 | $20.2M | $17.1M |
| Q4 25 | $-7.9M | $-11.9M | ||
| Q3 25 | $-2.3M | $-18.7M | ||
| Q2 25 | $-4.9M | $-18.3M | ||
| Q1 25 | $-3.9M | $-22.6M | ||
| Q4 24 | $-1.3M | $-22.3M | ||
| Q3 24 | $-1.8M | $-28.8M | ||
| Q2 24 | $-3.6M | $-22.7M | ||
| Q1 24 | $-5.2M | $-31.2M |
| Q4 25 | 56.1% | — | ||
| Q3 25 | 56.1% | — | ||
| Q2 25 | 54.3% | — | ||
| Q1 25 | 61.4% | — | ||
| Q4 24 | 63.4% | — | ||
| Q3 24 | 60.3% | — | ||
| Q2 24 | 60.4% | — | ||
| Q1 24 | 65.1% | — |
| Q4 25 | -51.1% | -60.5% | ||
| Q3 25 | -10.7% | -121.6% | ||
| Q2 25 | -23.1% | -103.2% | ||
| Q1 25 | -24.1% | -164.3% | ||
| Q4 24 | -6.5% | -138.8% | ||
| Q3 24 | -6.6% | -204.4% | ||
| Q2 24 | -11.5% | -134.6% | ||
| Q1 24 | -26.1% | -192.1% |
| Q4 25 | -52.5% | -64.1% | ||
| Q3 25 | -12.0% | -123.6% | ||
| Q2 25 | -25.0% | -99.7% | ||
| Q1 25 | -25.4% | -151.7% | ||
| Q4 24 | -5.3% | -131.4% | ||
| Q3 24 | -6.8% | -197.3% | ||
| Q2 24 | -13.0% | -126.1% | ||
| Q1 24 | -25.5% | -182.7% |
| Q4 25 | — | $-0.42 | ||
| Q3 25 | — | $-0.88 | ||
| Q2 25 | — | $-0.85 | ||
| Q1 25 | — | $-1.06 | ||
| Q4 24 | — | $-1.05 | ||
| Q3 24 | — | $-1.36 | ||
| Q2 24 | — | $-1.07 | ||
| Q1 24 | — | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $37.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.2M | $126.6M |
| Total Assets | $29.6M | $329.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $37.4M | ||
| Q3 25 | $7.6M | $32.3M | ||
| Q2 25 | $10.5M | $44.8M | ||
| Q1 25 | $14.3M | $60.2M | ||
| Q4 24 | $18.0M | $84.3M | ||
| Q3 24 | $16.1M | $37.2M | ||
| Q2 24 | $20.3M | $35.8M | ||
| Q1 24 | $17.5M | $63.5M |
| Q4 25 | $15.2M | $126.6M | ||
| Q3 25 | $22.6M | $64.7M | ||
| Q2 25 | $24.3M | $79.3M | ||
| Q1 25 | $27.0M | $93.5M | ||
| Q4 24 | $30.0M | $111.8M | ||
| Q3 24 | $30.6M | $128.8M | ||
| Q2 24 | $30.9M | $148.9M | ||
| Q1 24 | $33.0M | $166.1M |
| Q4 25 | $29.6M | $329.5M | ||
| Q3 25 | $40.1M | $280.7M | ||
| Q2 25 | $45.4M | $301.0M | ||
| Q1 25 | $49.8M | $323.0M | ||
| Q4 24 | $49.5M | $348.6M | ||
| Q3 24 | $52.1M | $376.7M | ||
| Q2 24 | $59.9M | $398.8M | ||
| Q1 24 | $55.7M | $413.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | $-11.7M |
| Free Cash FlowOCF − Capex | $-1.0M | $-11.8M |
| FCF MarginFCF / Revenue | -6.9% | -63.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-18.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.0M | $-11.7M | ||
| Q3 25 | $-1.6M | $-6.5M | ||
| Q2 25 | $-4.4M | $17.5M | ||
| Q1 25 | $-3.9M | $-13.5M | ||
| Q4 24 | $-9.0K | $-16.8M | ||
| Q3 24 | $-722.0K | $-10.4M | ||
| Q2 24 | $2.9M | $-14.8M | ||
| Q1 24 | $-6.0K | $-28.6M |
| Q4 25 | $-1.0M | $-11.8M | ||
| Q3 25 | $-1.6M | $-7.9M | ||
| Q2 25 | $-4.4M | $17.4M | ||
| Q1 25 | — | $-16.0M | ||
| Q4 24 | — | $-25.5M | ||
| Q3 24 | — | $-19.4M | ||
| Q2 24 | $2.9M | $-21.3M | ||
| Q1 24 | $-42.0K | $-30.3M |
| Q4 25 | -6.9% | -63.6% | ||
| Q3 25 | -8.4% | -52.5% | ||
| Q2 25 | -22.7% | 94.7% | ||
| Q1 25 | — | -107.4% | ||
| Q4 24 | — | -150.6% | ||
| Q3 24 | — | -132.5% | ||
| Q2 24 | 10.3% | -118.6% | ||
| Q1 24 | -0.2% | -177.5% |
| Q4 25 | 0.0% | 0.8% | ||
| Q3 25 | 0.2% | 9.6% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.0% | 17.0% | ||
| Q4 24 | 0.0% | 51.6% | ||
| Q3 24 | 0.0% | 61.3% | ||
| Q2 24 | 0.0% | 36.4% | ||
| Q1 24 | 0.2% | 9.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
ENTA
Segment breakdown not available.
